US 12378256
Heterocyclic compound
granted A61KA61K31/4355A61K31/444
Quick answer
US patent 12378256 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4355, A61K31/444, A61K31/501, A61K31/506